Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa study of SNH-119014 tablets in adults with non-transfusion-dependent thalassemia
CTR20261588Phase 2Active
- Sponsor
- SinoHub Pharmaceutical
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SNH-119014 in Thalassaemia, hemoglobinopathies, sickle cell disease (SCD), sponsored by SinoHub Pharmaceutical. Started Jun 2026; status: active.
02
Drugs
SNH-119014
03
Conditions
Thalassaemiahemoglobinopathiessickle cell disease (SCD)
Beyond the preview
Go deeper on CTR20261588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261588.